v3.26.1
Statement -UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (1,441,466) $ (188,252)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 32,330 505
Amortization of intangible assets 183,427
Loss on disposal of equipment 1,275
Imputed and amortized interest 2,943
Amortized interest from notes payable 88,345
Loss on issuance of notes payable 250,997
Change in fair value of notes payable 274,867
Loss on extinguishment of notes payable 138,365
Stock based compensation to consultants 75,485
Amortization of operating lease right-of-use assets (28,985)
Deferred income taxes (110)
Accounts receivable (204,994)
Inventories 871,615
Amounts due from related parties (88,782)
Prepayments and other current assets (2,437,852)
Operating lease right-of-use assets, net 13,062
Accounts receivable, non-current 44,731
Accounts payable (393,891) 421
Accounts payable, related parties 4,422 1,728
Contract liabilities 1,382,316
Amounts due to related parties (4,581) (44,848)
Operating lease liabilities 18,894
Accrued expenses and other current liabilities (1,007,763) 103,173
Net cash used in operating activities (2,228,293) (124,330)
Cash flows from investing activities:    
Purchase of equipment (52,222) (789)
Cash acquired from the acquisition of AI UltraProd 364,311
Net cash (used in) provided by investing activities (52,222) 363,522
Cash flows from financing activities:    
Issuance of common shares for cash 5,000
Proceeds from notes payable 1,003,200 26,372
Increase in amounts due to related parties 103,273
Redemption of notes payable (439,865)
Proceeds from short-term borrowings 2,417,048
Repayments on short-term borrowings (1,467,922)
Proceeds from a non-controlling shareholder 730,241
Net cash provided by financing activities 2,242,702 134,645
Net (decrease) increase in cash (37,813) 373,837
Cash and equivalents – beginning of period 233,825
Effects of exchange rate changes on cash 115,699
Cash and equivalents – end of period 311,711 373,837
Cash paid for income taxes
Cash paid for interest 67,448 25,577
Non-cash financing activities:    
Accretions of redeemable NCI to redemption value 46,227
Issuance of shares to consultants $ 75,485